Table 4.

GAS5 expression levels in MS patients compared with control group, based on age and sex of the participants

GAS5 expression		Controls no.	MS patients no.	Expression ratio	Standard error	P value	95% confidence interval
Total		50	50	0.6687	0.08	0.061	[-1.19, 0.08]
Male		23	19	0.8945	-0.227	0.561	[-1.25, 0.74]
Female		27	31	0.5459	0.411	0.061	[-1.84, 0.16]
<30 years	Male	6	4	0.9636	-0.01	0.476	[-4.16, 3.73]
	Female	3	7	0.1920	5.13	0.067	[-16.7, 10.3]
30–40 years	Male	8	5	1.7716	0.33	0.171	[-0.56, 2.77]
	Female	5	10	0.6850	1.11	0.206	[-3.05, 1.79]
>40 years	Male	9	10	0.5529	-0.96	0.156	[-2.93, 0.72]
	Female	19	14	0.5677	0.16	0.226	[-2.17, 0.74]